Abstract
Introduction

40
Lung diseases such as asthma, chronic obstructive pulmonary disease (COPD), 41 pneumonia, and acute respiratory distress syndrome (ARDS) feature inflammation of the 42 airway epithelium and are associated with hyperglycemia. This hyperglycemia increases 43 the risk of poor outcomes in hospitalized patients with lung injury (3, 6, 9, 29, 42) .
44
Hyperglycemia and insulin resistance are present almost immediately after lung injury,
45
and before the diagnosis of ventilator-associated pneumonia (34). Even several years
46
after an infection with pneumonia, there is an association between the disease, 47 hyperglycemia, and increased risk of death (22) . The link between hyperglycemia and 48 pulmonary disease is poorly understood, but it is thought to be due to insulin resistance 49 rather than beta cell dysfunction (12). The severity of inflammation during lung disease is 50 correlated with accompanying impairments in glucose homeostasis. However, it is 51 unclear if a primary inflammatory event localized in the airway epithelium as opposed to 52 accompanying comorbidities (e.g. obesity, hypoxia, steroid treatment) or the presence of 53 a specific pathogen (e.g. bacteria or virus) can impair insulin action.
54
Lung diseases and diabetes are both inflammatory disorders. Lung inflammation is 55 associated with systemic inflammation (41). However lung inflammation also is 56 accompanied with comorbidities (e.g. obesity) that also induce inflammation. It is 57 unknown whether isolated lung inflammation in the absence of other comorbidities that 58 are known to increase inflammation and diabetes risk can induce system inflammation 59 and insulin resistance. We predicted that targeted airway inflammation would induce systemic insulin resistance. We used doxycycline to induce the airway epithelium 61 expression of a constitutively active Iκβ kinase (IKK2), an activator of the key 62 inflammatory regulator: nuclear factor kappa-B (NF-κB), in a transgenic mouse model.
63
When activated, IKK2 triggers the activation and nuclear translocation of NF-κB. NF-κB 
89
Surgical Procedures
90
The surgical procedures for implanting chronic catheters have been described previously
91
(1, 2, 37). Six days before a metabolic study, mice were anesthetized with isoflurane.
92
The left common carotid artery and right jugular vein were catheterized allowing for 
96
After surgery, the animals were individually housed, and body weight was allowed to 97 recover to within 10% of presurgical weight.
98
In Vivo Metabolic Experiments
99
Five days prior to metabolic experiments, chronically catheterized IKTA (C57BL/6J) 100 mice and controls were given access to water that contained (1.0g/L) doxycycline 
113
samples for tracer analysis were collected at t=-10, 0, 80, 90, 100, 120, 122, 125, 130, 
121
H&E staining, BAL cell collection and counting
122
Mice were euthanized after 5 days of Dox. At the time of sacrifice, lungs were lavaged
123
(1.0 mL sterile normal saline), and then perfused and fixed in formalin for 24 hours.
124
After fixation, lungs were embedded in paraffin, sectioned (5 μm) and stained with 125 hematoxylin and eosin (H&E). The bronchoalveolar lavage (BAL) fluid was centrifuged at 300xg for 10 min to separate cells from supernatant. Total and differential cell counts 127 were assessed as previously described (45). Cytokine (TNF-α, IL-1β, 128 content in BAL samples and plasma was assessed using multiplex technology
129
(MAGPIX ® , Millipore Billerica, Mass).
130
Western Blots
131
Liver protein samples were homogenized using an extraction buffer (50 mM Tris, 1 mM 132 EDTA, 1 mM EGTA, 10% glycerol, 1% Triton X-100 at pH 7.5 with 1 mM DTT, 1 mM 133 PMSF, 5 ug/mL protease inhibitor cocktail, 10 ug/mL trypsin inhibitor, 50 mM NaF, and 5
134
mM NaPP added before homogenization). After homogenization, tissues were 
155
Glycogen phosphorylase and Glycogen synthase Assays
156
Liver samples were homogenized (~10 mg in 500 μL) in buffer (50 mM Tris:pH 6.8, 100 157 mM NaF, 10 mM EDTA, 5.0 mM dithioerythritol, and 0.5% glycogen). Glycogen synthase 
183
Results
184
The activation NF-κβ in the lung airway epithelium causes lung inflammation and circulating levels of these same cytokines were increased in the plasma of the IKTA 194 mice ( Figure 1F ). IL-1β in both BAL and plasma was at or below the limit of detection 195 (3.2 pg/mL; data not reported) in both groups.
196
Lung airway inflammation impairs the action of insulin in vivo 197
After the 5 days of Dox treatment, C57BL6/J background mice underwent 
210
(rate of appearance of glucose) was not significantly different between groups ( Figure 3B ). Lastly, insulin's ability to suppress endogenous glucose production (Endo-Ra) was 212 blunted in the IKTA mice ( Figure 3C ).
213
Lung airway inflammation triggered systemic and liver inflammation
214
Hypoxemia from airway inflammation could lead to systemic insulin resistance.
215
Hypoxemia was not present as arterial PO 2 on the day of the clamp study was 93±9 vs. 
223
To understand the mechanism that accounts for the failure of insulin to suppress hepatic 224 glucose production in the IKTA mice, we assessed markers of the insulin signaling G6pc. In addition, PEPCK protein content was not different between the control and 230 IKTA mice ( Figure 6D ).Glycogen synthase and phosphorylase activity was measured to 231 determine if activity of these enzymes was different between groups. Insulin stimulates 232 the activity of glycogen synthase and inhibits the activity glycogen phosphorylase. The total activity of glycogen phosphorylase was not increased (p=0.07) in the IKTA mice 234 (Fig. 7A) , and the activity ratio of glycogen phosphorylase (0.83±0.03 vs. 0.85 +/-0.02; 235 control vs. IKTA) was not different between groups. Total activity (Fig. 7B) 
238
Given that increased glycogenolysis was not detected, we examined the factors 
245
Discussion
246
Lung diseases are associated with an increased risk for development of type 2 diabetes,
247
As they also increase known risk factors (e.g. obesity), the direct link between lung 248 inflammation and glucose dyshomeostasis is unclear (6, 40, 44) . This study highlights a 
260
The model system that was used in these studies triggers lung airway inflammation 
272
the lower glucose requirements were primarily due to a failure of insulin to suppress 273 hepatic glucose production (Fig 2C) . In control mice, insulin completely suppressed 274 hepatic glucose production. In contrast, hepatic glucose production in the IKTA mice was 275 not suppressed despite higher insulin concentrations.
The inability of insulin to inhibit the production of glucose by the liver was associated 277 with hepatic inflammation and systemic inflammation. Like other tissues, the liver had an 278 increase in the expression of pro-inflammatory makers (Il6, Tnf, and Nos2), which could 279 induce hepatic insulin resistance (21). In addition, circulating concentrations of TNFα, IL-280 5, and IL-6 were increased, which could also contribute to the observed hepatic insulin 
293
trigger an inflammatory response in the liver (7, 8, 18, 19, 24, 30) . There are reports
294
showing a crosstalk between the liver and the lung; although most of the prior work is 295 focused on the impact of liver injury on lung inflammation (23). The present data suggest 296 that the crosstalk is reciprocal; inflammation in the lung induces hepatic inflammation.
297
Besides inducing inflammation in the liver, airway inflammation increased CHOP expression. CHOP, which is commonly increased with ER stress, may contribute to the 299 hepatic insulin resistance (27). However BiP, another ER stress marker, was not 300 increased. Therefore, activation of ER stress alone would not be enough to explain the 301 hepatic insulin resistance.
302
The insulin resistance that occurs due to inflammation typically results in suppression of 
317
The increased production of glucose in the presence of insulin by the liver in IKTA mice 318 could result from increased gluconeogenesis. As mentioned, the activities of glycogen insulin resistance and hyperglycemia in these individuals (3, 6, 9, 17, 29, 42, 47 
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